These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2947643)

  • 1. Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets.
    D'Angelo A; Lockhart MS; D'Angelo SV; Taylor FB
    Blood; 1987 Jan; 69(1):231-7. PubMed ID: 2947643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
    Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
    Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells.
    de Fouw NJ; van Hinsbergh VW; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):176-82. PubMed ID: 3496680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.
    van Hinsbergh VW; Bertina RM; van Wijngaarden A; van Tilburg NH; Emeis JJ; Haverkate F
    Blood; 1985 Feb; 65(2):444-51. PubMed ID: 3917696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1.
    Urano T; Castellino FJ; Ihara H; Suzuki Y; Ohta M; Suzuki K; Mogami H
    J Thromb Haemost; 2003 Dec; 1(12):2615-20. PubMed ID: 14675098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
    Fay WP; Owen WG
    Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new function for activated protein C: activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes--platelet suspensions stimulated by phorbol diester.
    Taylor FB; Lockhart MS
    Thromb Res; 1985 Jan; 37(1):155-64. PubMed ID: 3920776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor.
    Gladson CL; Schleef RR; Binder BR; Loskutoff DJ; Griffin JH
    Blood; 1989 Jul; 74(1):173-81. PubMed ID: 2787675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin infusion in endotoxin-treated rabbits reduces the plasma levels of plasminogen activator inhibitor: evidence for a protein-C-mediated mechanism.
    Colucci M; Triggiani R; Cavallo LG; Semeraro N
    Blood; 1989 Nov; 74(6):1976-82. PubMed ID: 2508792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
    Kobayashi H; Moniwa N; Gotoh J; Sugimura M; Terao T
    Cancer Res; 1994 Jan; 54(1):261-7. PubMed ID: 8261450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin signal transduction mechanisms in human glomerular epithelial cells.
    He CJ; Peraldi MN; Adida C; Rebibou JM; Meulders Q; Sraer JD; Rondeau E
    J Cell Physiol; 1992 Mar; 150(3):475-83. PubMed ID: 1537879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
    Keijer J; Linders M; Wegman JJ; Ehrlich HJ; Mertens K; Pannekoek H
    Blood; 1991 Sep; 78(5):1254-61. PubMed ID: 1715220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
    Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
    J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
    Erickson LA; Ginsberg MH; Loskutoff DJ
    J Clin Invest; 1984 Oct; 74(4):1465-72. PubMed ID: 6434594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.
    Kruithof EK; Gudinchet A; Bachmann F
    Thromb Haemost; 1988 Feb; 59(1):7-12. PubMed ID: 3129809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM; Loskutoff DJ
    Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.